Alkem Laboratories announced the launch of generic empagliflozin and its combinations in India under the brand name Empanorm at prices that are approximately 80% lower than the innovator products.

Empagliflozin is an SGLT-2 (Sodium-Glucose Co-Transporter-2) inhibitor indicted for use in the treatment of type-2 diabetes mellitus.

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

The price of commonly used diabetes drug empagliflozin has been slashed by almost one-tenth, with the entry of its generic ...

Alkem Laboratories Ltd announced the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm” at prices that are approximately 80% lower than the innovator ...

The price of empagliflozin, a commonly prescribed diabetes drug, has been slashed by a staggering 90% in India. This ...

LaLiga and EA Sports are teaming up once again with the shared goal of eliminating racism in all aspects of society, including football and gaming.

We took Adobe Firefly for a test spin, diving into generative art in hopes of finding a pragmatic purpose — a use for us ...

India needs coordination & cooperation of SLAs, CDSCO & industry to eradicate spurious drug menace: Dr Jagashetty: Nandita Vijayasimha, Bengaluru Wednesday, March 19, 2025, 08:00 ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

Late-night is emerging as a key battleground across the industry, with both quick-service and full-service brands vying for ...

Several domestic drug makers, including Mankind Pharma, have launched the diabetes drug Empagliflozin at significantly ...